FMP
NASDAQ
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
0.29 USD
0.0023 (0.793%)
Dr. Meeshanthini V. Dogan Ph.D.
Healthcare
Biotechnology
NASDAQ
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
0001870144
US14159C1036
14159C103
400 N Aberdeen St
855 226 9991
US
7
Jan 14, 2022